Browse by UCL people
Group by: Type | Date
Number of items: 261.
Article
Abd-Alazeez, M;
Ahmed, HU;
Arya, M;
Charman, SC;
Anastasiadis, E;
Freeman, A;
Emberton, M;
(2013)
The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-Can it rule out clinically significant prostate cancer?
Urol Oncol
10.1016/j.urolonc.2013.06.007.
|
 |
|
Abd-Alazeez, M;
Kirkham, A;
Ahmed, HU;
Arya, M;
Anastasiadis, E;
Charman, SC;
Freeman, A;
(2014)
Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard.
Prostate Cancer and Prostatic Disease
, 17
(1)
pp. 40-46.
10.1038/pcan.2013.43.
|
 |
|
Ahmed, Hashim Uddin;
Arya, Manit;
Freeman, Alex;
Emberton, Mark;
(2012)
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?
The Lancet Oncology
, 13
(11)
e509 - e517.
10.1016/S1470-2045(12)70388-1.
|
 |
|
Ahmed, HU;
Brown, LC;
Kaplan, R;
Parker, C;
Emberton, M;
(2017)
Diagnostic accuracy of the PROMIS study Reply.
[Letter].
The Lancet
, 390
(10092)
p. 362.
10.1016/S0140-6736(17)31595-7.
|
|
Ahmed, HU;
El-Shater Bosaily, A;
Brown, LC;
Gabe, R;
Kaplan, R;
Parmar, MK;
Collaco-Moraes, Y;
... PROMIS study group; + view all
(2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Lancet
, 389
(10071)
pp. 815-822.
10.1016/S0140-6736(16)32401-1.
|
|
|
Ahmed, HU;
Hindley, RG;
Dickinson, L;
Freeman, A;
Kirkham, AP;
Sahu, M;
Scott, R;
... Emberton, M; + view all
(2012)
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Lancet Oncology
, 13
(6)
622 - 632.
10.1016/S1470-2045(12)70121-3.
|
|
|
Ahmed, HU;
Huber, P;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
... Winkler, M; + view all
(2020)
An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer.
Journal of Endourology
, 34
(6)
pp. 641-646.
10.1089/end.2019.0613.
|
|
Asif, Aqua;
Nathan, Arjun;
Ng, Alexander;
Khetrapal, Pramit;
Chan, Vinson Wai-Shun;
Giganti, Francesco;
Allen, Clare;
... PRIME Trial Group; + view all
(2023)
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
BMJ Open
, 13
(4)
, Article e070280. 10.1136/bmjopen-2022-070280.
|
|
Azzouzi, A-R;
Emberton, M;
PCM301 study investigators, .;
(2017)
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer - Authors' reply.
Lancet Oncology
, 18
(4)
, Article e188. 10.1016/S1470-2045(17)30163-8.
|
|
Azzouzi, AR;
Barret, E;
Bennet, J;
Moore, C;
Taneja, S;
Muir, G;
Villers, A;
... Emberton, M; + view all
(2015)
TOOKAD (R) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer.
World Journal of Urology
, 33
(7)
pp. 945-953.
10.1007/s00345-015-1505-8.
|
|
|
Azzouzi, AR;
Vincendeau, S;
Barret, E;
Cicco, A;
Kleinclauss, F;
van der Poel, HG;
Stief, CG;
... PCM301 Study Group; + view all
(2016)
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
The Lancet Oncology
, 18
(2)
pp. 181-191.
10.1016/S1470-2045(16)30661-1.
|
|
Bass, EJ;
Donaldson, IA;
Freeman, A;
Jameson, C;
Punwani, S;
Moore, C;
Arya, M;
... Ahmed, HU; + view all
(2017)
Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.
Prostate Cancer and Prostatic Diseases
, 20
pp. 311-317.
10.1038/pcan.2017.13.
|
|
Bass, EJ;
Freeman, A;
Jameson, C;
Punwani, S;
Moore, CM;
Arya, M;
Emberton, M;
(2018)
Prostate Cancer Diagnostic Pathway: Is a One-stop Cognitive Mri Targeted Biopsy Service a Realistic Goal in Everyday Practice? A Pilot Cohort in a Tertiary Referral Centre in the UK.
BMJ Open
, 8
(10)
, Article e024941. 10.1136/bmjopen-2018-024941.
|
|
|
Bass, EJ;
Orczyk, C;
Grey, A;
Freeman, A;
Jameson, C;
Punwani, S;
Ramachandran, N;
... Ahmed, HU; + view all
(2019)
Targeted biopsy of the prostate: improvement in detection of high-grade cancer, or the Will Rogers phenomenon?
BJU International
, 124
(4)
pp. 643-648.
10.1111/bju.14806.
|
|
Bonmati, E;
Hu, Y;
Villarini, B;
Rodell, R;
Martin, P;
Han, L;
Donaldson, I;
... Barratt, DC; + view all
(2018)
Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal MR/US-guided prostate interventions.
Medical Physics
10.1002/mp.12814.
(In press).
|
|
Bosaily, AE-S;
Parker, C;
Brown, LC;
Gabe, R;
Hindley, RG;
Kaplan, R;
Emberton, M;
(2015)
PROMIS - Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.
CONTEMPORARY CLINICAL TRIALS
, 42
pp. 26-40.
10.1016/j.cct.2015.02.008.
|
|
|
Bosaily, AE-S;
Frangou, E;
Ahmed, HU;
Emberton, M;
Punwani, S;
Kaplan, R;
Brown, LC;
... PROMIS Group; + view all
(2020)
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.
European Urology
, 78
(4)
pp. 503-511.
10.1016/j.eururo.2020.03.002.
|
|
Brown, C.T.;
Yap, T.;
Cromwell, D.A.;
Rixon, L.;
Steed, L.;
Mulligan, K.;
Mundy, A.;
... Emberton, M.; + view all
(2007)
Self management for men with lower urinary tract symptoms: randomised controlled trial.
BMJ
, 334
(7583)
pp. 25-28.
10.1136/bmj.39010.551319.AE.
|
|
|
Brown, LC;
Ahmed, HU;
Faria, R;
El-Shater Bosaily, A;
Gabe, R;
Kaplan, RS;
Parmar, M;
... Emberton, M; + view all
(2018)
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Health Technology Assessment
, 22
(39)
xxxiii, 1-175.
10.3310/hta22390.
|
|
|
Callender, T;
Emberton, M;
Morris, S;
Eeles, R;
Kote-Jarai, Z;
Pharoah, PDP;
Pashayan, N;
(2019)
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
PLOS Medicine
, 16
(12)
, Article e1002998. 10.1371/journal.pmed.1002998.
|
|
|
Callender, T;
Emberton, M;
Morris, S;
Pharoah, PDP;
Pashayan, N;
(2021)
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer.
JAMA Network Open
, 4
(3)
, Article e2037657. 10.1001/jamanetworkopen.2020.37657.
|
|
|
Campelo, S;
Valerio, M;
Ahmed, HU;
Hu, Y;
Arena, SL;
Neal, RE;
Emberton, M;
(2017)
An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.
APL Bioengineering
, 1
(1)
, Article 016101. 10.1063/1.5005828.
|
|
|
Carmona Echeverria, LM;
Haider, A;
Freeman, A;
Stopka-Farooqui, U;
Rosenfeld, A;
Simpson, BS;
Hu, Y;
... Whitaker, HC; + view all
(2020)
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Scientific Reports
, 10
, Article 17177. 10.1038/s41598-020-73524-z.
|
|
|
Cathcart, P;
Ribeiro, L;
Moore, C;
Ahmed, HU;
Leslie, T;
Arya, M;
Orczyk, C;
... Emberton, M; + view all
(2021)
Outcomes of the RAFT Trial: Robotic surgery After Focal Therapy.
BJU International
, 128
(4)
pp. 504-510.
10.1111/bju.15432.
|
|
Chau, EM;
Arya, M;
Petrides, N;
Aldin, Z;
McKenzie, J;
Emberton, M;
Virdi, J;
... Kasivisvanathan, V; + view all
(2018)
Performance characteristics of multiparametric-MRI at a non-academic hospital using transperineal template mapping biopsy as a reference standard.
International Journal of Surgery Open
, 10
pp. 66-71.
10.1016/j.ijso.2018.01.002.
|
|
|
Chowdhury, Rafat;
Mueller, Christoph A;
Smith, Lorna;
Gong, Fiona;
Papoutsaki, Marianthi-Vasiliki;
Rogers, Harriet;
Syer, Tom;
... Punwani, Shonit; + view all
(2022)
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade.
Journal of Magnetic Resonance Imaging
10.1002/jmri.28467.
(In press).
|
|
Cole, AP;
Langbein, BJ;
Giganti, F;
Fennessy, FM;
Tempany, CM;
Emberton, M;
(2022)
Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer.
The British Journal of Radiology
, 95
(1131)
, Article 20210840. 10.1259/bjr.20210840.
|
|
Correas, Jean-Michel;
Dariane, Charles;
Renard Penna, Raphaele;
Ghai, Sangeet;
Bladou, Franck;
Cathelineau, Xavier;
Ward, John F;
... de la Rosette, Jean; + view all
(2025)
Imaging in focal therapy: advanced ultrasound imaging and mpMRI—a comprehensive review.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-025-01017-z.
(In press).
|
|
Crosby, David;
Bhatia, Sangeeta;
Brindle, Kevin M;
Coussens, Lisa M;
Dive, Caroline;
Emberton, Mark;
Esener, Sadik;
... Balasubramanian, Shankar; + view all
(2022)
Early detection of cancer.
Science
, 375
(6586)
, Article eaay9040. 10.1126/science.aay9040.
|
|
Dickinson, L;
Ahmed, HU;
Emberton, M;
van der Meulen, J;
Allen, C;
Kirkham, AP;
Punwani, S;
... Villers, A; + view all
(2013)
Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway.
Urologic Oncology: Seminars and Original Investigations
, 31
(3)
281- 284.
10.1016/j.urolonc.2012.02.004.
|
|
|
Dickinson, L;
Ahmed, HU;
Hindley, RG;
McCartan, N;
Freeman, A;
Allen, C;
Emberton, M;
(2017)
Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
Urologic Oncology: Seminars and Original Investigations
, 35
(1)
30.e9-30.e15.
10.1016/j.urolonc.2016.07.015.
|
|
Dickinson, L;
Ahmed, HU;
Kirkham, A;
Allen, C;
Freeman, A;
Barber, J;
Hindley, R;
... on behalf of the INDEX Study Group; + view all
(2013)
A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.
Contemporary Clinical Trials
, 36
(1)
pp. 68-80.
10.1016/j.cct.2013.06.005.
|
|
|
Dickinson, L;
Hu, Y;
Ahmed, HU;
Allen, C;
Kirkham, AP;
Emberton, M;
Barratt, D;
(2013)
Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system.
BJU Int
, 112
(5)
pp. 594-601.
10.1111/bju.12223.
|
|
|
Dikaios, N;
Alkalbani, J;
Sidhu, HS;
Fujiwara, T;
Abd-Alazeez, M;
Kirkham, A;
Allen, C;
... Punwani, S; + view all
(2015)
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI.
Eur Radiol
, 25
(2)
523 - 532.
10.1007/s00330-014-3386-4.
|
|
|
Dikaios, N;
Atkinson, D;
Tudisca, C;
Purpura, P;
Forster, M;
Ahmed, H;
Beale, T;
... Punwani, S; + view all
(2017)
A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis.
Computerized Medical Imaging and Graphics
, 56
pp. 1-10.
10.1016/j.compmedimag.2017.01.003.
|
|
Donaldson, IA;
Alonzi, R;
Barratt, D;
Barret, E;
Berge, V;
Bott, S;
Bottomley, D;
... Ahmed, HU; + view all
(2014)
Focal Therapy: Patients, Interventions, and Outcomes-A Report from a Consensus Meeting.
Eur Urol
, 67
(4)
pp. 771-777.
10.1016/j.eururo.2014.09.018.
|
|
|
El-Shater Bosaily, A;
Valerio, M;
Hu, Y;
Freeman, A;
Jameson, C;
Brown, L;
Kaplan, R;
... Ahmed, HU; + view all
(2016)
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.
Prostate Cancer and Prostatic Diseases
, 19
(3)
pp. 258-263.
10.1038/pcan.2016.7.
|
|
|
Eldred-Evans, D;
Neves, JB;
Simmons, LAM;
Kanthabalan, A;
McCartan, N;
Shah, TT;
Arya, M;
... Ahmed, HU; + view all
(2020)
The added value of diffusion-weighted images and dynamic contrast-enhancement in multi-parametric MRI for the detection of clinically significant prostate cancer in the PICTURE trial.
BJU International
, 125
(3)
pp. 391-398.
10.1111/bju.14953.
|
|
Elliott, D;
Hamdy, FC;
Leslie, TA;
Rosario, D;
Dudderidge, T;
Hindley, R;
Emberton, M;
... Donovan, JL; + view all
(2018)
Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation versus radical prostatectomy for unilateral localised prostate cancer.
BJU International
, 122
(6)
pp. 970-977.
10.1111/bju.14432.
|
|
Emberton, M;
(2019)
Dropping the GAD – just a fad? The case for a simpler, quicker, safer and cheaper prostate magnetic resonance imaging.
BJU International
, 124
(2)
pp. 183-184.
10.1111/bju.14801.
|
|
Emberton, M;
(2019)
To see or not to see — what renders prostate cancer visible?
Nature Reviews Urology
, 16
pp. 274-275.
10.1038/s41585-019-0167-5.
|
|
Emberton, M;
(2018)
Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?
BJU International
, 121
(5)
pp. 676-677.
10.1111/bju.14088.
|
|
Emberton, M;
(2017)
An end to the phenomenon of 'upgrading' in early prostate cancer?
BJU International
, 119
(4)
pp. 506-507.
10.1111/bju.13671.
|
|
Emberton, M;
(2017)
Is a negative prostate biopsy a risk factor for a prostate cancer related death?
Lancet Oncol
, 18
(2)
pp. 162-163.
10.1016/S1470-2045(17)30024-4.
|
|
Emberton, M;
(2016)
Doubling our precision of risk stratification in early prostate cancer: too good to be true?
[Editorial comment].
BJU International
, 117
(1)
pp. 8-9.
10.1111/bju.13119.
|
|
Emberton, M;
(2015)
Are men who are biopsied without a prior prostate MRI getting sub-standard care?
[Editorial comment].
British Journal of Urology (BJU) International
, 116
(6)
pp. 837-839.
10.1111/bju.13067.
|
|
Evans, Christopher;
Bercades, Georgia;
Ambler, Gareth;
Wilson, Matthew;
Brew-Graves, Chris;
Baldini, Cinzia;
Begum-Ali, Nazma;
... Moonesinghe, Suneetha Ramani; + view all
(2025)
Little Journey: a phase III randomised controlled trial of a psychological preparation and education smartphone application for management of paediatric perioperative anxiety compared with standard care in children undergoing ambulatory surgery - study protocol.
BMJ Open
, 15
(2)
, Article e090696. 10.1136/bmjopen-2024-090696.
|
|
|
Falagario, UG;
Pellegrino, F;
Fanelli, A;
Guzzi, F;
Bartoletti, R;
Cash, H;
Pavlovich, C;
... Giannarini, G; + view all
(2024)
Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-024-00827-x.
(In press).
|
|
Faria, R;
Soares, MO;
Spackman, E;
Ahmed, HU;
Brown, LC;
Kaplan, R;
Emberton, M;
(2018)
Re: Jochen Walz. The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31-2.
[Letter].
European Urology
, 73
(6)
e151-e152.
10.1016/j.eururo.2018.02.003.
|
|
Faria, R;
Soares, MO;
Spackman, E;
Ahmed, HU;
Brown, LC;
Kaplan, R;
Emberton, M;
(2018)
Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).
European Urology
, 73
(1)
pp. 23-30.
10.1016/j.eururo.2017.08.018.
|
|
Faure Walker, NA;
Norris, JM;
Shah, TT;
Yap, T;
Cathcart, P;
Moore, CM;
Ahmed, HU;
... Minhas, S; + view all
(2018)
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Urologic Oncology: Seminars and Original Investigations
, 36
(2)
pp. 67-76.
10.1016/j.urolonc.2017.12.002.
|
|
Fiard, G;
Norris, JM;
Nguyen, TA;
Stavrinides, V;
Olivier, J;
Emberton, M;
Moore, CM;
(2020)
What to expect from a non-suspicious prostate MRI? A review = Que peut-on attendre d’une IRM prostatique non suspecte ? Une revue de la littérature.
Progrès en Urologie
, 30
(16)
pp. 986-999.
10.1016/j.purol.2020.09.012.
|
|
Fiard, G;
Stavrinides, V;
Chambers, ES;
Heavey, S;
Freeman, A;
Ball, R;
Akbar, AN;
(2021)
Cellular senescence as a possible link between prostate diseases of the ageing male.
Nature Reviews Urology
, 18
pp. 597-610.
10.1038/s41585-021-00496-8.
|
|
Fiard, Gaelle;
Chowdhury, Aminah;
Potter, Aneirin R;
Pook, Celina J;
Kelly, Daniel;
Emberton, Mark;
Yap, Tet;
(2022)
Detailing Sexual Outcomes After Focal Therapy for Localised Prostate Cancer: A Systematic Review and Meta-analysis.
European Urology Focus
, 8
(4)
pp. 926-941.
10.1016/j.euf.2021.09.009.
|
|
Fiard, G;
Kelly, D;
Yap, T;
Emberton, M;
(2020)
Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study.
BMJ Open
, 10
(12)
10.1136/bmjopen-2020-045500.
|
|
|
Ghavami, N;
Hu, Y;
Gibson, E;
Bonmati, E;
Emberton, M;
Moore, CM;
Barratt, DC;
(2019)
Automatic segmentation of prostate MRI using convolutional neural networks: Investigating the impact of network architecture on the accuracy of volume measurement and MRI-ultrasound registration.
Medical Image Analysis
, 58
, Article 101558. 10.1016/j.media.2019.101558.
|
|
|
Giganti, F;
Lindner, S;
Piper, JW;
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
Allen, C;
(2021)
Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program.
European Radiology Experimental
, 5
(1)
, Article 48. 10.1186/s41747-021-00245-x.
|
|
|
Giganti, F;
Stavrinides, V;
Stabile, A;
Osinibi, E;
Orczyk, C;
Radtke, JP;
Freeman, A;
... Moore, CM; + view all
(2020)
Prostate cancer measurements on serial MRI during active surveillance: it’s time to be PRECISE.
British Journal of Radiology
, 93
(1116)
, Article 20200819. 10.1259/bjr.20200819.
|
|
Giganti, Francesco;
Ng, Alexander;
Asif, Aqua;
Chan, Vinson Wai-Shun;
Rossiter, Marimo;
Nathan, Arjun;
Khetrapal, Pramit;
... PRIME Quality Improvement Group; + view all
(2023)
Global Variation in Magnetic Resonance Imaging Quality of the Prostate.
Radiology
, 309
(1)
, Article e231130. 10.1148/radiol.231130.
|
|
|
Giganti, F;
Allen, C;
Emberton, M;
Moore, CM;
Kasivisvanathan, V;
PRECISION study group, .;
(2020)
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.
European Urology Oncology
, 3
(5)
pp. 615-619.
10.1016/j.euo.2020.06.007.
|
|
Giganti, F;
Allen, C;
Piper, JW;
Mirando, D;
Stabile, A;
Punwani, S;
Kirkham, A;
... Moore, CM; + view all
(2019)
Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program.
Magnetic Resonance Imaging
, 57
pp. 34-39.
10.1016/j.mri.2018.10.013.
|
|
Giganti, F;
Allen, C;
Stavrinides, V;
Stabile, A;
Haider, A;
Freeman, A;
Pashayan, N;
... Kirkham, A; + view all
(2021)
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
British Journal of Radiology
10.1259/bjr.20210321.
(In press).
|
|
|
Giganti, F;
Dinneen, E;
Kasivisvanathan, V;
Haider, A;
Freeman, A;
Kirkham, A;
Punwani, S;
... Allen, C; + view all
(2021)
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
European Radiology
10.1007/s00330-021-08169-1.
(In press).
|
|
|
Giganti, F;
Gambarota, G;
Moore, CM;
Robertson, NL;
McCartan, N;
Jameson, C;
Bott, SRJ;
... Kirkham, A; + view all
(2018)
Prostate cancer detection using quantitative T2 and T2‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance.
Journal of Magnetic Resonance Imaging
, 47
(6)
pp. 1646-1653.
10.1002/jmri.25891.
|
|
Giganti, F;
Kasivisvanathan, V;
Kirkham, A;
Punwani, S;
Emberton, M;
Moore, CM;
Allen, C;
(2021)
Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.
The British Journal of Radiology
, 94
, Article 20210415. 10.1259/bjr.20210415.
|
|
|
Giganti, F;
Kirkham, A;
Allen, C;
Punwani, S;
Orczyk, C;
Emberton, M;
Moore, CM;
(2020)
Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations.
American Journal of Roentgenology
10.2214/AJR.20.23985.
(In press).
|
|
Giganti, F;
Kirkham, A;
Kasivisvanathan, V;
Papoutsaki, M-V;
Punwani, S;
Emberton, M;
Moore, CM;
(2021)
Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists.
Insights into Imaging
, 12
, Article 59. 10.1186/s13244-021-00996-6.
|
|
|
Giganti, F;
Moore, CM;
Robertson, NL;
McCartan, N;
Jameson, C;
Bott, SRJ;
Winkler, M;
... Kirkham, A; + view all
(2017)
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.
EUROPEAN RADIOLOGY
, 27
(11)
pp. 4767-4774.
10.1007/s00330-017-4858-0.
|
|
Giganti, F;
Pecoraro, M;
Fierro, D;
Campa, R;
Del Giudice, F;
Punwani, S;
Kirkham, A;
... Panebianco, V; + view all
(2020)
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.
Magnetic Resonance Imaging
, 67
pp. 50-58.
10.1016/j.mri.2019.12.007.
|
|
Giganti, F;
Pecoraro, M;
Stavrinides, V;
Stabile, A;
Cipollari, S;
Sciarra, A;
Kirkham, A;
... Panebianco, V; + view all
(2019)
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study.
European Radiology
10.1007/s00330-019-06557-2.
(In press).
|
|
|
Giganti, F;
Rosenkrantz, AB;
Villeirs, G;
Panebianco, V;
Stabile, A;
Emberton, M;
Moore, CM;
(2019)
The Evolution of MRI of the Prostate: The Past, the Present, and the Future.
American Journal of Roentgenology
10.2214/AJR.18.20796.
(In press).
|
|
Giganti, F;
Stabile, A;
Giona, S;
Marenco, J;
Orczyk, C;
Moore, CM;
Allen, C;
... Punwani, S; + view all
(2019)
Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.
Magnetic Resonance Imaging
, 58
pp. 143-147.
10.1016/j.mri.2019.02.003.
|
|
Giganti, F;
Stabile, A;
Stavrinides, V;
Osinibi, E;
Retter, A;
Orczyk, C;
Panebianco, V;
... Moore, CM; + view all
(2020)
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort.
European Radiology
10.1007/s00330-020-07256-z.
(In press).
|
|
|
Gill, IS;
Azzouzi, A-R;
Emberton, M;
Coleman, JA;
Coeytaux, E;
Scherz, A;
Scardino, PT;
(2018)
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.
Journal of Urology
, 200
(4)
pp. 786-792.
10.1016/j.juro.2018.05.121.
|
|
Goldberg, H;
Ahmad, AE;
Chandrasekar, T;
Klotz, L;
Emberton, M;
Haider, MA;
Taneja, SS;
... Wallis, CJD; + view all
(2019)
Comparison of MRI- and TRUS-Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy-Naive Men: A Systematic Review and Meta-Analysis.
The Journal of Neurology
10.1097/JU.0000000000000595.
(In press).
|
|
Gravas, Stavros;
Malde, Sachin;
Cornu, Jean-Nicolas;
Gacci, Mauro;
Gratzke, Christian;
Herrmann, Thomas RW;
Karavitakis, Markos;
... de la Rosette, Jean JMCH; + view all
(2023)
From BPH to male LUTS: a 20-year journey of the EAU guidelines.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-023-00700-3.
(In press).
|
|
Green, S;
Tuck, S;
Long, J;
Green, T;
Green, A;
Ellis, P;
Haire, A;
... Van Hemelrijck, M; + view all
(2021)
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
Research Involvement and Engagement
, 7
(1)
, Article 81. 10.1186/s40900-021-00322-w.
|
|
|
Grey, ADR;
Scott, R;
Shah, B;
Acher, P;
Liyanage, S;
Pavlou, M;
Omar, R;
... Ahmed, HU; + view all
(2022)
Re: Multiparametric Ultrasound versus Multiparametric MRI to Diagnose Prostate Cancer (CADMUS): A Prospective, Multicentre, Paired-Cohort, Confirmatory Study Editorial Comment.
The Journal of Urology
, 208
(2)
pp. 476-477.
10.1097/JU.0000000000002745.
|
|
Grey, A;
Scott, R;
Charman, S;
van der Meulen, J;
Frinking, P;
Acher, P;
Liyanage, S;
... Ahmed, HU; + view all
(2018)
The CADMUS trial – Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer.
Contemporary Clinical Trials
, 66
pp. 86-92.
10.1016/j.cct.2017.10.011.
|
|
Grummet, J;
Gorin, MA;
Popert, R;
O'Brien, T;
Lamb, AD;
Hadaschik, B;
Radtke, JP;
... Woo, HH; + view all
(2020)
“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-020-0204-8.
(In press).
|
|
|
Guillaumier, S;
Peters, M;
Arya, M;
Afzal, N;
Charman, S;
Dudderidge, T;
Hosking-Jervis, F;
... Ahmed, HU; + view all
(2018)
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
European Urology
, 74
(4)
pp. 422-429.
10.1016/j.eururo.2018.06.006.
|
|
|
Habashy, David;
Reddy, Deepika;
Peters, Max;
Shah, Taimur T;
van Son, Marieke;
van Rossum, Peter;
Tanaka, Mariana Bertoncelli;
... Dudderidge, Tim; + view all
(2023)
Evaluation of Outcomes following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience.
The Journal of Urology
10.1097/JU.0000000000003443.
|
|
Hadi, MM;
Nesbitt, H;
Masood, H;
Sciscione, F;
Patel, S;
Ramesh, BS;
Emberton, M;
... Nomikou, N; + view all
(2021)
Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer.
Journal of Controlled Release
, 329
pp. 76-86.
10.1016/j.jconrel.2020.11.040.
|
|
|
Hamid, S;
Donaldson, IA;
Hu, Y;
Rodell, R;
Villarini, B;
Bonmati, E;
Tranter, P;
... Ahmed, HU; + view all
(2019)
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
European Urology
, 75
(5)
pp. 733-740.
10.1016/j.eururo.2018.08.007.
|
|
|
Haroon, A;
Afaq, A;
Nuthakki, S;
Freeman, A;
Biassoni, L;
Fanti, S;
Beheshti, M;
... Bomanji, J; + view all
(2018)
Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with Ga-68-PSMA, radiolabelled choline and Ga-68-DOTATATE.
[Review].
Nuclear Medicine Communications
, 39
(3)
pp. 196-204.
10.1097/MNM.0000000000000797.
|
|
Haroon, A;
Ahmed, HU;
Cathcart, P;
Almuhaideb, A;
Kayani, I;
Dickson, J;
Kirkham, A;
... Bomanji, J; + view all
(2016)
F-18-FECH PET/CT to Assess Clinically Significant Disease in Prostate Cancer: Correlation With Maximum and Total Cancer Core Length Obtained via MRI-Guided Template Mapping Biopsies.
American Journal of Roentgenology
, 207
(6)
pp. 1297-1306.
10.2214/AJR.15.15679.
|
|
Haroon, A;
Syed, R;
Endozo, R;
Allie, R;
Freeman, A;
Emberton, M;
Bomanji, J;
(2017)
Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
Nuclear Medicine Communications
, 38
(5)
pp. 407-414.
10.1097/MNM.0000000000000665.
|
|
Hu, Y;
Gibson, E;
Ahmed, HU;
Moore, CM;
Emberton, M;
Barratt, DC;
(2015)
Population-based prediction of subject-specific prostate deformation for MR-to-ultrasound image registration.
Medical Image Analysis
, 26
(1)
pp. 332-344.
10.1016/j.media.2015.10.006.
|
|
|
Hu, Y;
Kasivisvanathan, V;
Simmons, L;
Clarkson, M;
Thompson, S;
Shah, T;
Ahmed, H;
... Barratt, D; + view all
(2017)
Development and Phantom Validation of a 3D-Ultrasound-Guided System for Targeting MRI-visible Lesions during Transrectal Prostate Biopsy.
IEEE Transactions on Biomedical Engineering
, 64
(4)
pp. 946-958.
10.1109/TBME.2016.2582734.
|
|
Hu, Y;
Modat, M;
Gibson, E;
Li, W;
Ghavami, N;
Bonmati, E;
Wang, G;
... Vercauteren, T; + view all
(2018)
Weakly-supervised convolutional neural networks for multimodal image registration.
Medical Image Analysis
, 49
pp. 1-13.
10.1016/j.media.2018.07.002.
|
|
|
Huber, PM;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
Guillaumier, S;
... Ahmed, HU; + view all
(2020)
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound.
The Journal of Urology
, 203
pp. 1-9.
10.1097/JU.0000000000000747.
|
|
Huber, PM;
Afzal, N;
Arya, M;
Boxler, S;
Dudderidge, T;
Emberton, M;
Guillaumier, S;
... Ahmed, HU; + view all
(2020)
Focal HIFU therapy for anterior compared to posterior prostate cancer lesions.
World Journal of Urology
10.1007/s00345-020-03297-7.
(In press).
|
|
|
Johnston, EW;
Bonet-Carne, E;
Ferizi, U;
Yvernault, B;
Pye, H;
Patel, D;
Clemente, J;
... Punwani, S; + view all
(2019)
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Radiology
, 291
(2)
pp. 391-397.
10.1148/radiol.2019181749.
|
|
Johnston, EW;
Pye, H;
Bonet Carne, E;
Panagiotaki, E;
Patel, D;
Galazi, M;
Heavey, S;
... Punwani, S; + view all
(2016)
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer.
BMC Cancer
, 16
(816)
10.1186/s12885-016-2856-2.
|
|
Kanthabalan, A;
Abd-Alazeez, M;
Arya, M;
Allen, C;
Freeman, A;
Jameson, C;
Kirkham, A;
... Ahmed, HU; + view all
(2016)
Transperineal Magnetic Resonance Imaging-targeted Biopsy versus Transperineal Template Prostate Mapping Biopsy in the Detection of Localised Radio-recurrent Prostate Cancer.
Clinical Oncology
, 28
(9)
pp. 568-576.
10.1016/j.clon.2016.04.038.
|
|
Kanthabalan, A;
Arya, M;
Freeman, A;
Mitra, AV;
Payne, H;
Peters, M;
Shah, TT;
... Ahmed, HU; + view all
(2020)
Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
The Journal of Urology
, 204
(5)
pp. 950-955.
10.1097/JU.0000000000001201.
|
|
Kanthabalan, A;
Peters, M;
Van Vulpen, M;
McCartan, N;
Hindley, RG;
Emara, A;
Moore, MC;
... Ahmed, HU; + view all
(2017)
Focal Salvage HIFU in radiorecurrent prostate cancer.
BJU International
, 120
(2)
pp. 246-256.
10.1111/bju.13831.
|
|
Kasivisvanathan, Veeru;
Wai-Shun Chan, Vinson;
Clement, Keiran D;
Levis, Brooke;
Ng, Alexander;
Asif, Aqua;
Haider, Masoom A;
... VISION Study Collaborators; + view all
(2024)
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer.
European Urology
10.1016/j.eururo.2024.08.022.
(In press).
|
|
|
Kasivisvanathan, V;
Ahmed, H;
Cashman, S;
Challacombe, B;
Emberton, M;
Gao, C;
Lamb, BW;
... Smith, D; + view all
(2018)
The British Urology Researchers in Surgical Training (BURST) Research Collaborative: an alternative research model for carrying out large scale multi-centre urological studies.
BJU Int
, 121
(1)
pp. 6-9.
10.1111/bju.14040.
|
|
Kasivisvanathan, V;
Ambrosi, A;
Giganti, F;
Chau, E;
Kirkham, A;
Punwani, S;
Allen, C;
... Moore, CM; + view all
(2019)
A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI.
European Urology
, 75
(1)
pp. 203-204.
10.1016/j.eururo.2018.09.033.
|
|
Kasivisvanathan, V;
Emberton, M;
Ahmed, HU;
(2013)
Focal therapy for prostate cancer: rationale and treatment opportunities.
Clin Oncol (R Coll Radiol)
, 25
(8)
461 - 473.
10.1016/j.clon.2013.05.002.
|
|
|
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
(2018)
"Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate Biopsy.
[Editorial comment].
European Urology
, 74
(4)
pp. 411-412.
10.1016/j.eururo.2018.06.012.
|
|
Kasivisvanathan, V;
Emberton, M;
Moore, CM;
(2018)
MRI-Targeted Biopsy for Prostate-Cancer Diagnosis: The authors reply.
The New England Journal of Medicine
, 379
(6)
pp. 589-590.
10.1056/NEJMc1807507.
|
|
Kasivisvanathan, V;
Jichi, F;
Klotz, L;
Villers, A;
Taneja, SS;
Punwani, S;
Freeman, A;
... Moore, CM; + view all
(2017)
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol.
BMJ Open
, 7
(10)
, Article e017863. 10.1136/bmjopen-2017-017863.
|
|
|
Kasivisvanathan, V;
Rannikko, AS;
Borghi, M;
Panebianco, V;
Mynderse, LA;
Vaarala, MH;
Briganti, A;
... PRECISION Study Group Collaborators; + view all
(2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
The New England Journal of Medicine
10.1056/NEJMoa1801993.
(In press).
|
|
Kasivisvanathan, V;
Stabile, A;
Neves, JB;
Giganti, F;
Valerio, M;
Shanmugabavan, Y;
Clement, KD;
... Moore, CM; + view all
(2019)
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.
European Urology
, 76
(3)
pp. 284-303.
10.1016/j.eururo.2019.04.043.
|
|
Khadhouri, S;
Gallagher, KM;
MacKenzie, K;
Shah, TT;
Gao, C;
Moore, S;
Zimmermann, E;
... IDENTIFY Protocol Collaborators Group, .; + view all
(2020)
IDENTIFY: The investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer: A multicentre cohort study.
International Journal of Surgery Protocols
, 21
pp. 8-12.
10.1016/j.isjp.2020.02.002.
|
|
|
Kluytmans, A;
Fütterer, JJ;
Emberton, M;
Sedelaar, M;
Grutters, J;
(2019)
Exploring the risk-reward balance in focal therapy for prostate cancer - a contribution to the debate.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-018-0125-y.
(In press).
|
|
Lantz, Anna;
Nordlund, Per;
Falagario, Ugo;
Joderling, Fredrik;
Ozbek, Orhan;
Clements, Mark;
Discacciati, Andrea;
... Nordstrom, Tobias; + view all
(2023)
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer.
European Urology Open Science
, 51
pp. 89-94.
10.1016/j.euros.2023.03.003.
|
|
|
Latifoltojar, A;
Dikaios, N;
Ridout, A;
Moore, C;
Illing, R;
Kirkham, A;
Taylor, S;
... Punwani, S; + view all
(2015)
Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.
Prostate Cancer and Prostatic Disease
, 18
pp. 242-351.
10.1038/pcan.2015.33.
|
|
|
Li, Yiwen;
Fu, Yunguan;
Gayo, Iani JMB;
Yang, Qianye;
Min, Zhe;
Saeed, Shaheer U;
Yan, Wen;
... Hu, Yipeng; + view all
(2023)
Prototypical few-shot segmentation for cross-institution male pelvic structures with spatial registration.
Medical Image Analysis
, Article 102935. 10.1016/j.media.2023.102935.
(In press).
|
|
Light, Alexander;
Peters, Max;
Reddy, Deepika;
Kanthabalan, Abi;
Otieno, Marjorie;
Pavlou, Menelaos;
Omar, Rumana;
... Shah, Taimur T; + view all
(2023)
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
BJU International
10.1111/bju.16102.
|
|
Linch, M;
Goh, G;
Hiley, C;
Shanmugabavan, Y;
McGranahan, N;
Rowan, A;
Wong, YNS;
... Swanton, C; + view all
(2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Annals of Oncology
, 28
(10)
pp. 2472-2480.
10.1093/annonc/mdx355.
|
|
Lovegrove, C;
Miah, S;
El-Shater Bosaily, A;
Bott, S;
Brown, L;
Burns-Cox, N;
Dudderidge, T;
... Ahmed, HU; + view all
(2020)
Comparison of Transrectal Ultrasound Biopsy to Transperineal
Template Mapping Biopsies Stratified by Multiparametric
Magnetic Resonance Imaging Score in the PROMIS Trial.
The Journal of Urology
, 203
(1)
pp. 100-107.
10.1097/JU.0000000000000455.
|
|
Lovegrove, CE;
Peters, M;
Guillaumier, S;
Arya, M;
Afzal, N;
Dudderidge, T;
Hosking-Jervis, F;
... Minhas, S; + view all
(2020)
Evaluation of functional outcomes after a second focal high‐intensity focused ultrasonography (HIFU) procedure in men with primary localized, non‐metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry.
BJU International
, 125
(6)
pp. 853-860.
10.1111/bju.15004.
|
|
Lu, Yaozhi;
Aslani, Shahab;
Zhao, An;
Shahin, Ahmed;
Barber, David;
Emberton, Mark;
Alexander, Daniel C;
(2023)
A hybrid CNN-RNN approach for survival analysis in a Lung Cancer Screening study.
Heliyon
, 9
(8)
, Article e18695. 10.1016/j.heliyon.2023.e18695.
|
|
Magdeldin, T;
López-Dávila, V;
Pape, J;
Cameron, GW;
Emberton, M;
Loizidou, M;
Cheema, U;
(2017)
Engineering a vascularised 3D in vitro model of cancer progression.
Sci Rep
, 7
, Article 44045. 10.1038/srep44045.
|
|
|
Manfredi, M;
Mele, F;
Garrou, D;
Walz, J;
Fütterer, JJ;
Russo, F;
Vassallo, L;
... Valerio, M; + view all
(2017)
Multiparametric prostate MRI: technical conduct, standardized report and clinical use. A narrative review.
Minerva Urologica E Nefrologica
, 69
10.23736/S0393-2249.17.02846-6.
|
|
Marconi, L;
Stonier, T;
Tourinho-Barbosa, R;
Moore, C;
Ahmed, HU;
Cathelineau, X;
Emberton, M;
... Cathcart, P; + view all
(2019)
Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence.
European Urology
, 76
(1)
pp. 27-30.
10.1016/j.eururo.2019.03.007.
|
|
Marenco, J;
Kasivisvanathan, V;
Emberton, M;
(2019)
New standards in prostate biopsy.
Archivos Españoles de Urología
, 72
(2)
pp. 142-149.
|
|
Marenco, J;
Orczyk, C;
Collins, T;
Moore, C;
Emberton, M;
(2019)
Role of MRI in planning radical prostatectomy: what is the added value?
World Journal of Urology
, 37
pp. 1289-1292.
10.1007/s00345-019-02762-2.
|
|
Marra, G;
Valerio, M;
Emberton, M;
Heidenreich, A;
Crook, JM;
Bossi, A;
Pisters, LL;
(2019)
Salvage Local Treatments After Focal Therapy for Prostate Cancer.
European Urology Oncology
, 2
(5)
pp. 526-538.
10.1016/j.euo.2019.03.008.
|
|
Marsden, T;
Ahmed, HU;
Emberton, M;
(2021)
An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging–based diagnostic pathway with donation of tissue, blood, and urine for biomarker analyses.
European Urology
, 80
(4)
pp. 398-399.
10.1016/j.eururo.2021.06.011.
|
|
Marsden, T;
Lomas, DJ;
McCartan, N;
Hadley, J;
Tuck, S;
Brown, L;
Haire, A;
... ReIMAGINE Study Group; + view all
(2021)
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI.
BMJ Open
, 11
(9)
, Article e048144. 10.1136/bmjopen-2020-048144.
|
|
|
Marsden, T;
McCartan, N;
Hadley, J;
Tuck, S;
Brown, L;
Haire, AJ;
Moss, CL;
... ReIMAGINE Study Group; + view all
(2021)
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging.
European Urology Focus
, 7
(3)
pp. 503-505.
10.1016/j.euf.2021.03.027.
|
|
Mehta, P;
Antonelli, M;
Ahmed, HU;
Emberton, M;
Punwani, S;
Ourselin, S;
(2021)
Computer-aided diagnosis of prostate cancer using multiparametric MRI and clinical features: A patient-level classification framework.
Medical Image Analysis
, 73
, Article 102153. 10.1016/j.media.2021.102153.
|
|
Mehta, P;
Antonelli, M;
Singh, S;
Grondecka, N;
Johnston, EW;
Ahmed, HU;
Emberton, M;
... Ourselin, S; + view all
(2021)
AutoProstate: Towards Automated Reporting of Prostate MRI for Prostate Cancer Assessment Using Deep Learning.
Cancers
, 13
(23)
, Article 6138. 10.3390/cancers13236138.
|
|
|
Miah, S;
Ahmed, HU;
Freeman, A;
Emberton, M;
(2016)
Does true Gleason pattern 3 merit its cancer descriptor?
Nature Reviews Urology
, 13
(9)
pp. 541-548.
10.1038/nrurol.2016.141.
|
|
Miah, S;
Eldred-Evans, D;
Simmons, LAM;
Shah, TT;
Kanthabalan, A;
Arya, M;
Winkler, M;
... Ahmed, HU; + view all
(2018)
Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.
The Journal of Urology
, 200
(6)
pp. 1235-1240.
10.1016/j.juro.2018.06.033.
|
|
Moonesinghe, SR;
Harris, S;
Mythen, MG;
Rowan, KM;
Haddad, FS;
Emberton, M;
Grocott, MP;
(2014)
Survival after postoperative morbidity: a longitudinal observational cohort study.
Br J Anaesth
, 113
(6)
977 - 984.
10.1093/bja/aeu224.
|
|
|
Moore, CM;
Azzouzi, A-R;
Barret, E;
Villers, A;
Muir, GH;
Barber, NJ;
Bott, S;
... Emberton, M; + view all
(2015)
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.
BJU International
, 116
(6)
pp. 888-896.
10.1111/bju.12816.
|
|
|
Moore, CM;
Robertson, NL;
Jichi, F;
Damola, A;
Ambler, G;
Giganti, F;
Ridout, AJ;
... Emberton, M; + view all
(2017)
The effect of dutasteride on MRI-defined prostate cancer lesions: MAPPED (Magnetic resonance imaging in Primary Prostate Cancer after Exposure to Dutasteride) - a randomized placebo-controlled, double-blind clinical trial.
The Journal of Urology
, 197
(4)
pp. 1006-1013.
10.1016/j.juro.2016.11.090.
|
|
Morka, N;
Simpson, BS;
Emberton, M;
Norris, JM;
(2021)
Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy. Eur Urol Oncol 2020;7:739–47.
European Urology Oncology
, 4
(1)
pp. 127-128.
10.1016/j.euo.2020.12.015.
|
|
Morka, N;
Norris, JM;
Emberton, M;
Kelly, D;
(2021)
Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-021-00404-6.
(In press).
|
|
|
Morka, N;
Simpson, BS;
Ball, R;
Freeman, A;
Kirkham, A;
Kelly, D;
Whitaker, HC;
... Norris, JM; + view all
(2021)
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.
BMJ Open
, 11
(5)
, Article e047664. 10.1136/bmjopen-2020-047664.
|
|
|
Morote, Juan;
Pye, Hayley;
Campistol, Miriam;
Celma, Anna;
Regis, Lucas;
Semidey, Maria;
de Torres, Ines;
... Emberton, Mark; + view all
(2023)
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
BJU International
, 132
(2)
pp. 188-195.
10.1111/bju.15998.
|
|
Neves, J;
Cullen, D;
Lee, G;
Walkden, M;
Bandula, S;
Patki, P;
Barod, R;
... Tran, M; + view all
(2019)
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses.
BMJ Open
, 9
(6)
, Article e030965. 10.1136/bmjopen-2019-030965.
|
|
Norris, JM;
Ball, R;
Freeman, A;
Ghei, M;
Kirkham, A;
Oldroyd, R;
Whitaker, HC;
... Emberton, M; + view all
(2021)
Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
Urology
, 153
pp. 6-7.
10.1016/j.urology.2021.03.031.
|
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Ball, R;
Freeman, A;
Kelly, D;
Kirkham, A;
... Emberton, M; + view all
(2021)
Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.
BJU International
, 127
(2)
pp. 169-170.
10.1111/bju.15295.
|
|
Norris, JM;
Simpson, BS;
Ball, R;
Freeman, A;
Kirkham, A;
Parry, MA;
Moore, CM;
... Emberton, M; + view all
(2021)
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research.
European Urology
, 79
(3)
pp. 325-326.
10.1016/j.eururo.2020.12.017.
|
|
Norris, JM;
Carmona Echeverria, LM;
Bott, SRJ;
Brown, LC;
Burns-Cox, N;
Dudderidge, T;
El-Shater Bosaily, A;
... Emberton, M; + view all
(2020)
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.
European Urology
10.1016/j.eururo.2020.04.029.
|
|
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: High Gleason Grade and Increased Tumour Volume are Not the Only Important Histopathological Features.
BJU International
, 126
(2)
pp. 237-239.
10.1111/bju.15085.
|
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Ball, R;
Freeman, A;
Kelly, D;
Kirkham, A;
... Emberton, M; + view all
(2020)
Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.
BMJ Open
, 10
(10)
, Article e039735. 10.1136/bmjopen-2020-039735.
|
|
|
Norris, JM;
Kasivisvanathan, V;
Allen, C;
Ball, R;
Freeman, A;
Ghei, M;
Kirkham, A;
... Emberton, M; + view all
(2020)
Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol.
Methods and Protocols
, 3
(2)
, Article 26. 10.3390/mps3020026.
|
|
|
Norris, JM;
Simmons, LAM;
Kanthabalan, A;
Freeman, A;
McCartan, N;
Moore, CM;
Punwani, S;
... Ahmed, HU; + view all
(2021)
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study.
European Urology Open Science
, 30
pp. 16-24.
10.1016/j.euros.2021.06.003.
|
|
|
Norris, JM;
Simpson, BS;
Freeman, A;
Kirkham, A;
Whitaker, HC;
Emberton, M;
(2020)
Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis.
The FASEB Journal
, 34
pp. 14150-14159.
10.1096/fj.202001466R.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.
European Urology Open Science
, 20
pp. 37-47.
10.1016/j.euros.2020.06.006.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis.
BMJ Open
, 10
(1)
, Article e034611. 10.1136/bmjopen-2019-034611.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Kasivisvanathan, V;
Allen, C;
Ball, R;
Freeman, A;
... Emberton, M; + view all
(2020)
Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It's time to take stock.
BJU International
, 125
(3)
pp. 340-342.
10.1111/bju.14919.
|
|
Noweski, A;
Roosen, A;
Lebdai, S;
Barret, E;
Emberton, M;
Benzaghou, F;
Apfelbeck, M;
... Azzouzi, AR; + view all
(2018)
Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).
European Urology Focus
10.1016/j.euf.2018.04.003.
(In press).
|
|
Nowinski, S;
Santaolalla, A;
O'Leary, B;
Loda, M;
Mirchandani, A;
Emberton, M;
Van Hemelrijck, M;
(2018)
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.
Oncotarget
, 9
(16)
pp. 12812-12824.
10.18632/oncotarget.24400.
|
|
|
Nyga, A;
Loizidou, M;
Emberton, M;
Cheema, U;
(2013)
A novel tissue engineered three-dimensional in vitro colorectal cancer model.
Acta Biomaterialia
, 9
(8)
pp. 7917-7926.
10.1016/j.actbio.2013.04.028.
|
|
|
Nyga, A;
Neves, J;
Loizidou, M;
Emberton, M;
Cheema, U;
(2016)
The next level of 3D tumour models: immunocompetence.
Drug Discovery Today
, 21
(9)
pp. 1421-1428.
10.1016/j.drudis.2016.04.010.
|
|
Olivier, J;
Stavrinides, V;
Kay, J;
Freeman, A;
Pye, H;
Ahmed, Z;
Carmona Echeverria, L;
... Whitaker, HC; + view all
(2018)
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates.
The Prostate
, 78
(16)
pp. 1229-1237.
10.1002/pros.23698.
|
|
Orczyk, C;
Barratt, D;
Brew-Graves, C;
Peng Hu, Y;
Freeman, A;
McCartan, N;
Potyka, I;
... Ahmed, HU; + view all
(2021)
Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Journal of Urology
, 205
(4)
pp. 1090-1099.
10.1097/JU.0000000000001567.
|
|
Orczyk, C;
Emberton, M;
(2017)
Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology: A. Priester, S. Natarajan, P. Khoshnoodi, D. J. Margolis, S. S. Raman, R. E. Reiter, J. Huang, W. Grundfest and L. S. Marks J Urol 2017;197:320–326.
[Letter].
The Journal of Urology
, 198
(6)
p. 1436.
10.1016/j.juro.2017.07.086.
|
|
Orczyk, C;
Villers, A;
Rusinek, H;
Lepennec, V;
Bazille, C;
Giganti, F;
Mikheev, A;
... Valable, S; + view all
(2019)
Prostate cancer heterogeneity: texture analysis score based on multiple MRI sequences for detection, stratification and selection of lesions at time of biopsy.
BJU International
, 124
(1)
pp. 76-86.
10.1111/bju.14603.
|
|
Ourselin, S;
Emberton, M;
Vercauteren, T;
(2016)
From computer-assisted intervention research to clinical impact: The need for a holistic approach.
[Editorial comment].
Medical Image Analysis
, 33
pp. 72-78.
10.1016/j.media.2016.06.018.
|
|
|
Pape, J;
Emberton, M;
Cheema, U;
(2021)
3D Cancer Models: The Need for a Complex Stroma, Compartmentalization and Stiffness.
Frontiers in Bioengineering and Biotechnology
, 9
, Article 660502. 10.3389/fbioe.2021.660502.
|
|
|
Pape, J;
Magdeldin, T;
Ali, M;
Walsh, C;
Lythgoe, M;
Emberton, M;
Cheema, U;
(2019)
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
European Journal of Cancer
, 119
pp. 179-193.
10.1016/j.ejca.2019.07.005.
|
|
|
Pape, J;
Magdeldin, T;
Stamati, K;
Nyga, A;
Loizidou, M;
Emberton, M;
Cheema, U;
(2020)
Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma.
British Journal of Cancer
, 123
pp. 1178-1190.
10.1038/s41416-020-0973-9.
|
|
Pape, J;
Stamati, K;
Al Hosni, R;
Uchegbu, IF;
Schatzlein, AG;
Loizidou, M;
Emberton, M;
(2021)
Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel Response.
International Journal of Molecular Sciences
, 22
(8)
, Article 4289. 10.3390/ijms22084289.
|
|
|
Peretsman, Samuel J;
Emberton, Mark;
Fleshner, Neil;
Shoji, Sunao;
Bahler, Clinton D;
Miller, Larry E;
(2024)
High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis.
World Journal of Urology
, 42
, Article 175. 10.1007/s00345-024-04840-6.
|
|
Peters, M;
Kanthabalan, A;
Shah, TT;
McCartan, N;
Moore, CM;
Arya, M;
Van der Voort van Zyp, JR;
... Ahmed, HU; + view all
(2018)
Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Urologic Oncology
, 36
(1)
13.e1-13.e10.
10.1016/j.urolonc.2017.08.022.
|
|
Peters, M;
van der Voort van Zyp, JR;
Moerland, MA;
Hoekstra, CJ;
van de Pol, S;
Westendorp, H;
Maenhout, M;
... van Vulpen, M; + view all
(2016)
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
Brachytherapy
, 15
(3)
pp. 296-305.
10.1016/j.brachy.2016.01.004.
|
|
Peters, M;
van Zyp, JRNVDV;
Moerland, MA;
Hoekstra, CJ;
van de Pol, S;
Westendorp, H;
Maenhout, M;
... van Vulpen, M; + view all
(2016)
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.
Radiotherapy and Oncology
, 119
(1)
pp. 104-110.
10.1016/j.radonc.2016.02.002.
|
|
Pierrard, V;
Lebdai, S;
Kleinclauss, F;
Azzouzi, A-R;
Terrier, JE;
Fortier, E;
Joniau, S;
... Ruffion, A; + view all
(2019)
Radical prostatectomy after vascular-targeted photodynamic therapy (VTP) with TOOKAD® : feasibility, early and intermediate results.
The Journal of Urology
, 201
(2)
pp. 315-321.
10.1016/j.juro.2018.08.084.
|
|
Pye, H;
Singh, S;
Norris, JM;
Carmona Echeverria, LM;
Stavrinides, V;
Grey, A;
Dinneen, E;
... Whitaker, HC; + view all
(2021)
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.
Cancers
, 13
(8)
, Article 1985. 10.3390/cancers13081985.
|
|
|
Radtke, JP;
Giganti, F;
Wiesenfarth, M;
Stabile, A;
Marenco, J;
Orczyk, C;
Kasivisvanathan, V;
... Moore, CM; + view all
(2019)
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS.
PLoS One
, 14
(8)
, Article e0221350. 10.1371/journal.pone.0221350.
|
|
|
Rakauskas, A;
Shah, TT;
Peters, M;
Randeva, JS;
Hosking-Jervis, F;
Schmainda, MJ;
Orczyck, C;
... Ahmed, HU; + view all
(2021)
Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
Urologic Oncology: Seminars and Original Investigations
10.1016/j.urolonc.2021.04.017.
(In press).
|
|
|
Reddy, D;
Peters, M;
Shah, TT;
van Son, M;
Tanaka, MB;
Huber, PM;
Lomas, D;
... Ahmed, HU; + view all
(2022)
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
European Urology
, 81
(4)
pp. 407-413.
10.1016/j.eururo.2022.01.005.
|
|
Reddy, Deepika;
van Son, Marieke;
Peters, Max;
Bertoncelli Tanaka, Mariana;
Dudderidge, Tim;
Cullen, Emma;
Ho, Carmen Lok Tung;
... Ahmed, Hashim U; + view all
(2023)
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Journal of Medical Economics
, 26
(1)
pp. 1099-1107.
10.1080/13696998.2023.2251849.
|
|
Reddy, D;
Shah, TT;
Dudderidge, T;
McCracken, S;
Arya, M;
Dobbs, C;
Emberton, M;
... Ahmed, HU; + view all
(2020)
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial.
Contemporary Clinical Trials
, 93
, Article 105999. 10.1016/j.cct.2020.105999.
|
|
Rhudd, A;
McDonald, J;
Emberton, M;
Kasivisvanathan, V;
(2017)
The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve men.
Current Opinion in Urology
, 27
(5)
pp. 488-494.
10.1097/MOU.0000000000000415.
|
|
Ribeiro, L;
Stonier, T;
Stroman, L;
Tourinho-Barbosa, R;
Alghazo, O;
Winkler, M;
Dasgupta, P;
... Cathcart, P; + view all
(2021)
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
The Journal of Urology
, 205
(3)
pp. 791-799.
10.1097/JU.0000000000001382.
|
|
Ricketts, KP;
Cheema, U;
Nyga, A;
Castoldi, A;
Guazzoni, C;
Magdeldin, T;
Emberton, M;
... Loizidou, M; + view all
(2014)
A 3D in vitro cancer model as a platform for nanoparticle uptake and imaging investigations.
Small
, 10
(19)
3954 - 3961.
10.1002/smll.201400194.
|
|
|
Rivas, JG;
Giganti, F;
Álvarez-Maestro, M;
Freire, MJ;
Kasivisvanathan, V;
Martinez-Piñero, L;
Emberton, M;
(2018)
Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
European Urology Focus
10.1016/j.euf.2018.02.012.
(In press).
|
|
Robertson, NL;
Hu, Y;
Ahmed, HU;
Freeman, A;
Barratt, D;
Emberton, M;
(2014)
Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study.
Eur Urol
, 65
(3)
628 - 634.
10.1016/j.eururo.2012.12.057.
|
|
Rodriguez-Sanchez, Lara;
Cathelineau, Xavier;
De Reijke, Theo M;
Stricker, Phillip;
Emberton, Mark;
Lantz, Anna;
Miñana López, Bernardino;
... The FALCON group; + view all
(2025)
Refining partial gland ablation for localised prostate cancer: the FALCON project.
BJU International
10.1111/bju.16669.
(In press).
|
|
Rodríguez-Sánchez, Lara;
Emberton, Mark;
De Reijke, Theo;
Stricker, Phillip;
Miñana, Bernardino;
Bianco, Fernando;
Escrig, Jose Luis Dominguez;
... Sanchez-Salas, Rafael; + view all
(2023)
Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer.
The World Journal of Men's Health
, 41
, Article e80. 10.5534/wjmh.230160.
|
|
|
Santaolalla, A;
Hulsen, T;
Davis, J;
Ahmed, HU;
Moore, CM;
Punwani, S;
Attard, G;
... Van Hemelrijck, M; + view all
(2021)
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer.
Frontiers in Artificial Intelligence
, 4
, Article 769582. 10.3389/frai.2021.769582.
|
|
|
Satish, P;
Simpson, B;
Freeman, A;
Giganti, F;
Kirkham, A;
Orczyk, C;
Whitaker, H;
... Norris, JM; + view all
(2021)
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical Risk.
European Urology
, 80
(2)
pp. 263-265.
10.1016/j.eururo.2021.05.017.
|
|
Satish, P;
Emberton, M;
Norris, JM;
(2021)
Tumor Topography for Diagnosis of Prostate Cancer.
American Journal of Roentgenology
, Article W1. 10.2214/AJR.20.25410.
(In press).
|
|
Sculpher, M;
Bryan, S;
Fry, P;
De Winter, P;
Payne, H;
Emberton, M;
(2004)
Patients' preferences for the management of non-metastatic prostate cancer: Discrete choice experiment.
British Medical Journal
, 328
(7436)
pp. 382-384.
10.1136/bmj.37972.497234.44.
|
|
|
Shah, TT;
Kasivisvanathan, V;
Jameson, C;
Freeman, A;
Emberton, M;
Ahmed, HU;
(2015)
Histological outcomes after focal high‐intensity focused ultrasound and cryotherapy.
World Journal of Urology
, 33
(7)
pp. 955-964.
10.1007/s00345-015-1561-0.
|
|
Shah, TT;
Peters, M;
Kanthabalan, A;
McCartan, N;
Fatola, Y;
van Zyp, JVDV;
van Vulpen, M;
... Ahmed, HU; + view all
(2016)
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
Prostate Cancer and Prostatic Diseases
, 19
(3)
pp. 311-316.
10.1038/pcan.2016.23.
|
|
Shah, TT;
Reddy, D;
Peters, M;
Ball, D;
Kim, NH;
Gomez, EG;
Miah, S;
... Winkler, M; + view all
(2021)
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Prostate Cancer and Prostatic Diseases
, 24
pp. 567-574.
10.1038/s41391-020-00315-y.
|
|
Short, Emma;
Calimport, Stuart;
Bentley, Barry;
(2025)
Defining an ageing-related pathology, disease or syndrome: International Consensus Statement.
GeroScience
, 47
(2)
pp. 1713-1720.
10.1007/s11357-024-01315-9.
|
|
|
Sidhu, HS;
Benigno, S;
Ganeshan, B;
Dikaios, N;
Johnston, EW;
Allen, C;
Kirkham, A;
... Punwani, S; + view all
(2017)
"Textural analysis of multiparametric MRI detects transition zone prostate cancer".
European Radiology
, 27
(6)
pp. 2348-2358.
10.1007/s00330-016-4579-9.
|
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Barratt, D;
Charman, SC;
Freeman, A;
... Ahmed, HU; + view all
(2017)
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy.
British Journal of Cancer
, 116
pp. 1159-1165.
10.1038/bjc.2017.57.
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Barratt, D;
Charman, SC;
Freeman, A;
... Ahmed, HU; + view all
(2018)
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
The Journal of Urology
, 200
(6)
pp. 1227-1234.
10.1016/j.juro.2018.07.001.
|
|
Simmons, LAM;
Kanthabalan, A;
Arya, M;
Briggs, T;
Charman, SC;
Freeman, A;
Gelister, J;
... Ahmed, HU; + view all
(2018)
Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-018-0094-1.
|
|
Singh, PB;
Anele, C;
Dalton, E;
Barbouti, O;
Stevens, D;
Gurung, P;
Arya, M;
... Ahmed, HU; + view all
(2014)
Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy.
Eur Urol
, 66
(1)
12 - 19.
10.1016/j.eururo.2013.09.045.
|
|
Song, W;
Wu, L;
Magaz, A;
Wang, T;
Liu, C;
Darbyshire, A;
Loizidou, M;
... Birchall, M; + view all
(2018)
Stiffness memory of indirectly 3D-printed elastomer nanohybrid regulates, chondrogenesis and osteogenesis of human mesenchymal stem cells.
Biomaterials
, 186
pp. 64-79.
10.1016/j.biomaterials.2018.09.013.
|
|
|
Stabile, A;
Mazzone, E;
Cirulli, GO;
De Cobelli, F;
Grummet, J;
Thoeny, HC;
Emberton, M;
... Taneja, SS; + view all
(2021)
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis.
European Urology Oncology
, 4
(4)
pp. 519-528.
10.1016/j.euo.2020.11.008.
|
|
Stabile, A;
Giganti, F;
Emberton, M;
Moore, CM;
(2018)
MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years.
[Review].
Prostate Cancer and Prostatic Diseases
, 21
pp. 473-487.
10.1038/s41391-018-0071-8.
|
|
Stabile, A;
Giganti, F;
Rosenkrantz, AB;
Taneja, SS;
Villeirs, G;
Gill, IS;
Allen, C;
... Kasivisvanathan, V; + view all
(2020)
Multiparametric MRI for prostate cancer diagnosis: current status and future directions.
Nature Reviews Urology
, 17
pp. 41-61.
10.1038/s41585-019-0212-4.
|
|
Stabile, A;
Orczyk, C;
Giganti, F;
Moschini, M;
Allen, C;
Punwani, S;
Cathala, N;
... Moore, CM; + view all
(2020)
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series.
European Urology
, 78
(2)
pp. 155-160.
10.1016/j.eururo.2020.04.068.
|
|
Stabile, A;
Orczyk, C;
Hosking-Jervis, F;
Giganti, F;
Arya, M;
Hindley, RG;
Dickinson, L;
... Moore, CM; + view all
(2019)
Medium term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using HIFU for primary localized prostate cancer.
BJU International
, 124
(3)
pp. 431-440.
10.1111/bju.14710.
|
|
Stamati, K;
Redondo, PA;
Nyga, A;
Neves, JB;
Tran, M;
Emberton, M;
Cheema, U;
(2020)
The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic 3D renal tumouroids.
Journal of Tissue Engineering
, 11
10.1177/2041731420920597.
|
|
|
Stavrinides, V;
Giganti, F;
Allen, C;
Kirkham, A;
Punwani, S;
Freeman, A;
Norris, J;
... Emberton, M; + view all
(2021)
Follow-Up of Men With PI-RADS 4 or 5 Abnormality on Prostate MRI and Non-Malignant Pathologic Findings on Initial Targeted Prostate Biopsy.
[Letter].
The Journal of Urology
, 205
(5)
pp. 1526-1528.
10.1097/JU.0000000000001589.
|
|
Stavrinides, Vasilis;
Eksi, Ece;
Finn, Ron;
Texeira-Mendes, Larissa;
Rana, Sarina;
Trahearn, Nick;
Grey, Alistair;
... Orczyk, Clement; + view all
(2023)
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.
European Urology Focus
10.1016/j.euf.2023.03.011.
(In press).
|
|
Stavrinides, Vasilis;
Norris, Joseph M;
Karapanagiotis, Solon;
Giganti, Francesco;
Grey, Alistair;
Trahearn, Nick;
Freeman, Alex;
... PROMIS Group; + view all
(2023)
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
Radiology
, 307
(1)
, Article 220762. 10.1148/radiol.220762.
|
|
Stavrinides, V;
Freeman, A;
Ball, R;
Haider, A;
Pashayan, N;
Moore, CM;
Emberton, M;
(2021)
Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. Letter.
Journal of Urology
, 205
(4)
pp. 1233-1234.
10.1097/JU.0000000000001587.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2020)
Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51.
European Urology
, 78
(4)
e166.
10.1016/j.eururo.2020.07.010.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2020)
Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll’s Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51.
European Urology
, 78
(3)
e112-e113.
10.1016/j.eururo.2020.06.038.
|
|
Stavrinides, V;
Giganti, F;
Emberton, M;
Moore, CM;
(2019)
MRI in active surveillance: a critical review.
Prostate Cancer and Prostatic Diseases
, 22
pp. 5-15.
10.1038/s41391-018-0077-2.
|
|
Stavrinides, V;
Giganti, F;
Punwani, S;
Allen, C;
Kirkham, A;
Freeman, A;
Ball, R;
... Moore, CM; + view all
(2020)
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
The Journal Of Urology
, 24
(5)
pp. 1065-1066.
10.1097/JU.0000000000001295.
|
|
Stavrinides, V;
Giganti, F;
Trock, B;
Punwani, S;
Allen, C;
Kirkham, A;
Freeman, A;
... Moore, CM; + view all
(2020)
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.
European Urology
10.1016/j.eururo.2020.03.035.
(In press).
|
|
|
Stavrinides, V;
Papageorgiou, G;
Danks, D;
Giganti, F;
Pashayan, N;
Trock, B;
Freeman, A;
... Moore, CM; + view all
(2021)
Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models.
Prostate Cancer and Prostatic Diseases
10.1038/s41391-021-00373-w.
(In press).
|
|
|
Stavrinides, V;
Syer, T;
Hu, Y;
Giganti, F;
Freeman, A;
Karapanagiotis, S;
Bott, SRJ;
... Emberton, M; + view all
(2020)
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.
European Urology
10.1016/j.eururo.2020.09.043.
|
|
|
Stonier, T;
Simson, N;
Shah, T;
Lobo, N;
Amer, T;
Lee, S-M;
Bass, E;
... Ahmed, HU; + view all
(2021)
The “Is mpMRI Enough” or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
European Urology Focus
, 7
(5)
pp. 1027-1034.
10.1016/j.euf.2020.09.012.
|
|
Tan, WP;
Rastinehad, AR;
Klotz, L;
Carroll, PR;
Emberton, M;
Feller, JF;
George, AK;
... Focal Therapy Consensus group., .; + view all
(2021)
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Urologic Oncology: Seminars and Original Investigations
, 39
(11)
781.e17-781.e24.
10.1016/j.urolonc.2021.01.027.
|
|
Taneja, SS;
Bennett, J;
Coleman, J;
Grubb, R;
Andriole, G;
Reiter, RE;
Marks, L;
... Emberton, M; + view all
(2016)
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.
The Journal of Urology
, 196
(4)
pp. 1096-1103.
10.1016/j.juro.2016.05.113.
|
|
Thomas, Maya;
Murali, Sanjana;
Simpson, Benjamin Scott S;
Freeman, Alex;
Kirkham, Alex;
Kelly, Daniel;
Whitaker, Hayley C;
... Norris, Joseph M; + view all
(2023)
Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis.
BMJ Open
, 13
(8)
, Article e074009. 10.1136/bmjopen-2023-074009.
|
|
Tran, M;
Latifoltojar, A;
Neves, J;
Papoutsaki, M-V;
Gong, Y;
Comment, A;
Costa, A;
... Punwani, S; + view all
(2019)
First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma.
BJR Case Reports
, 5
(3)
, Article 20190003. 10.1259/bjrcr.20190003.
|
|
|
Tran, M;
Neves, J;
Stamati, K;
Redondo, P;
Cope, A;
Brew-Graves, C;
Williams, N;
... Emberton, M; + view all
(2019)
Acceptability and feasibility study of patient-specific ‘tumouroids’ as personalised treatment screening tools: protocol for prospective tissue and data collection of participants with confirmed or suspected renal cell carcinoma.
International Journal of Surgery Protocols
, 14
pp. 24-29.
10.1016/j.isjp.2019.03.019.
|
|
|
Valerio, M;
Ahmed, HU;
Emberton, M;
Lawrentschuk, N;
Lazzeri, M;
Montironi, R;
Nguyen, PL;
... Polascik, TJ; + view all
(2014)
The role of focal therapy in the management of localised prostate cancer: a systematic review.
European Urology
, 66
(4)
pp. 732-751.
10.1016/j.eururo.2013.05.048.
|
|
Valerio, M;
Anele, C;
Charman, SC;
van der Meulen, J;
Freeman, A;
Jameson, C;
Singh, PB;
... Ahmed, HU; + view all
(2015)
Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.
BJU International
10.1111/bju.13306.
|
|
Valerio, M;
Cerantola, Y;
Eggener, SE;
Lepor, H;
Polascik, TJ;
Villers, A;
Emberton, M;
(2017)
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
[Review].
European Urology
, 71
(1)
pp. 17-34.
10.1016/j.eururo.2016.08.044.
|
|
|
Valerio, M;
Dickinson, L;
Ali, A;
Ramachadran, N;
Donaldson, I;
Freeman, A;
Ahmed, HU;
(2014)
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
Contemp Clin Trials
, 39
(1)
pp. 57-65.
10.1016/j.cct.2014.07.006.
|
|
|
Valerio, M;
Dickinson, L;
Ali, A;
Ramachadran, N;
Donaldson, I;
Mccartan, N;
Freeman, A;
... Emberton, M; + view all
(2017)
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
The Journal of Urology
, 197
(3)
pp. 647-653.
10.1016/j.juro.2016.09.091.
|
|
Valerio, M;
El-Shater Bosaily, A;
Emberton, M;
Ahmed, HU;
(2014)
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Urologic Oncology: Seminars and Original Investigations
, 32
(6)
pp. 924-930.
10.1016/j.urolonc.2013.10.008.
|
|
|
Valerio, M;
Shah, TT;
Shah, P;
Mccartan, N;
Emberton, M;
Arya, M;
Ahmed, HU;
(2016)
Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Urologic Oncology: Seminars and Original Investigations
, 35
(4)
150.e1-150.e7.
10.1016/j.urolonc.2016.11.008.
|
|
van der Sar, ECA;
Kasivisvanathan, V;
Brizmohun, M;
Freeman, A;
Punwani, S;
Hamoudi, R;
Emberton, M;
(2019)
Management of Radiologically Indeterminate Magnetic Resonance Imaging Signals in Men at Risk of Prostate Cancer.
European Urology Focus
, 5
(1)
pp. 62-68.
10.1016/j.euf.2017.03.016.
|
|
van Son, MJ;
Peters, M;
Reddy, D;
Shah, TT;
Hosking-Jervis, F;
Robinson, S;
Lagendijk, JJW;
... Falconer, A; + view all
(2021)
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
Prostate Cancer and Prostatic Diseases
, 24
pp. 1120-1128.
10.1038/s41391-021-00369-6.
|
|
Warren, Hannah;
Wagner, Thomas;
El-Sheikh, Soha;
Campain, Nick;
Wah, Tze M;
O'Brien, Tim S;
Mendichovszky, Iosif A;
... Tran, Maxine GB; + view all
(2025)
[99mTc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study).
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-025-07525-3.
(In press).
|
|
|
Watson, V;
McCartan, N;
Krucien, N;
Abu, V;
Ikenwilo, D;
Emberton, M;
Ahmed, HU;
(2020)
Evaluating the Trade-offs Men with Localised Prostate Cancer Make Between the Risks and Benefits of Treatments: The COMPARE Study.
The Journal of Urology
, 204
(2)
pp. 273-280.
10.1097/JU.0000000000000754.
|
|
Willis, SR;
Ahmed, HU;
Moore, CM;
Donaldson, I;
Emberton, M;
Miners, AH;
van der Meulen, J;
(2014)
Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis.
BMJ Open
, 4
(6)
, Article e004895. 10.1136/bmjopen-2014-004895.
|
|
|
Wu, L;
Virdee, J;
Maughan, E;
Darbyshire, A;
Jell, G;
Loizidou, M;
Emberton, M;
... Song, W; + view all
(2025)
Corrigendum to “Stiffness memory nanohybrid scaffolds generated by indirect 3D printing for biologically responsive soft implants” [Acta Biomaterialia, 80, 2018, 188-202].
[Corrigendum].
Acta Biomaterialia
, 196
pp. 523-525.
10.1016/j.actbio.2025.01.052.
|
|
Wu, RC;
Lebastchi, AH;
Hadaschik, BA;
Emberton, M;
Moore, C;
Laguna, P;
Futterer, JJ;
(2021)
Role of MRI for the detection of prostate cancer.
World Journal of Urology
, 39
pp. 637-649.
10.1007/s00345-020-03530-3.
|
|
Wu, L;
Adrian, M;
Wang, T;
Liu, C;
Darbyshire, A;
Loizidou, M;
Emberton, M;
... Song, W; + view all
(2018)
Data of a Stiffness Softening Mechanism Effect on
Proliferation and Differentiation of a Human Bone
Marrow Derived Mesenchymal Stem Cell Line
Towards the Chondrogenic and Osteogenic
Lineages.
Data in Brief
, 21
pp. 133-142.
10.1016/j.dib.2018.09.068.
|
|
|
Wu, L;
Magaz, A;
Darbyshire, A;
Howkins, A;
Reynolds, A;
Boyd, IW;
Song, H;
... Song, W; + view all
(2019)
Thermoresponsive Stiffness Softening of Hierarchically Porous Nanohybrid Membranes Promotes Niches for Mesenchymal Stem Cell Differentiation.
Advanced Healthcare Materials
, 8
(10)
, Article 1801556. 10.1002/adhm.201801556.
|
|
Wu, L;
Magaz, A;
Huo, S;
Darbyshire, A;
Loizidou, M;
Emberton, M;
Birchall, M;
(2020)
Human airway-like multilayered tissue on 3D-TIPS printed thermoresponsive elastomer/collagen hybrid scaffolds.
Acta Biomaterialia
, 113
pp. 177-195.
10.1016/j.actbio.2020.07.013.
|
|
Wu, L;
Magaz, A;
Maughan, E;
Oliver, N;
Darbyshire, A;
Loizidou, M;
Emberton, M;
... Song, W; + view all
(2019)
Cellular responses to thermoresponsive stiffness memory elastomer nanohybrid scaffolds by 3D-TIPS.
Acta Biomaterialia
, 85
pp. 157-171.
10.1016/j.actbio.2018.12.019.
|
|
Wu, L;
Magaz, A;
Maughan, E;
Oliver, N;
Darbyshire, A;
Loizidou, M;
Emberton, M;
... Song, W; + view all
(2019)
Development data associated with effects of stiffness softening of 3D-TIPS elastomer nanohybrid scaffolds on tissue ingrowth, vascularization and inflammation in vivo.
Data in Brief
10.1016/j.dib.2019.01.012.
(In press).
|
|
|
Wu, L;
Virdee, J;
Maughan, E;
Darbyshire, A;
Jell, G;
Loizidou, M;
Emberton, M;
... Song, W; + view all
(2018)
Stiffness memory nanohybrid scaffolds generated by indirect 3D printing for biologically responsive soft implants.
Acta Biomaterialia
, 80
pp. 188-202.
10.1016/j.actbio.2018.09.016.
|
|
|
Yan, Wen;
Chiu, Bernard;
Shen, Ziyi;
Yang, Qianye;
Syer, Tom;
Min, Zhe;
Punwani, Shonit;
... Hu, Yipeng; + view all
(2024)
Combiner and HyperCombiner networks: Rules to combine multimodality MR images for prostate cancer localisation.
Medical Image Analysis
, 91
, Article 103030. 10.1016/j.media.2023.103030.
|
|
Zhao, Y;
Morka, N;
Simpson, BSS;
Freeman, A;
Kirkham, A;
Kelly, D;
Whitaker, HC;
... Norris, JM; + view all
(2021)
Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis.
BMJ Open
, 11
(12)
, Article e052277. 10.1136/bmjopen-2021-052277.
|
|
Book chapter
|
Neves, JB;
Emberton, M;
Kasivisvanathan, V;
(2017)
Management of an Elevated PSA and Biopsy Strategies in the Large Prostate.
In: Kasivisvanathan, V and Challacombe, B, (eds.)
The Big Prostate.
(pp. 41-51).
Springer: Cham, Switzerland.
|
Proceedings paper
|
Gibson, E;
Hu, Y;
Ghavami, N;
Ahmed, HU;
Moore, C;
Emberton, M;
Huisman, HJ;
(2018)
Inter-site Variability in Prostate Segmentation Accuracy Using Deep Learning.
In: Frangi, A and Schnabel, J and Davatzikos, C and Alberola-López, C and Fichtinger, G, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2018. MICCAI 2018. Lecture Notes in Computer Science.
(pp. pp. 506-514).
Springer: Cham, Switzerland.
|
|
Hu, Y;
Gibson, E;
Barratt, DC;
Emberton, M;
Noble, JA;
Vercauteren, T;
(2019)
Conditional Segmentation in Lieu of Image Registration.
In:
Proceedings of the nternational Conference on Medical Image Computing and Computer-Assisted Intervention MICCAI 2019.
(pp. pp. 401-409).
Springer: Shenzhen, China.
|
|
Hu, Y;
Gibson, E;
Ghavami, N;
Bonmati, E;
Moore, CM;
Emberton, M;
Vercauteren, T;
... Barratt, DC; + view all
(2018)
Adversarial deformation regularization for training image registration neural networks.
In: Frangi, AF and Schnabel, JA and Davatzikos, C and Alberola-López, C and Fichtinger, G, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2018: 21st International Conference, Granada, Spain, September 16-20, 2018, Proceedings, Part I.
(pp. pp. 774-782).
Springer: Cham, Switzerland.
|
|
Hu, Y;
Gibson, E;
Vercauteren, T;
Ahmed, H;
Emberton, M;
Moore, C;
Noble, JA;
(2017)
Intraoperative Organ Motion Models with an Ensemble of Conditional Generative Adversarial Networks.
In: Descoteaux, M and Maier-Hein, L and Franz, A and Jannin, P and Collins, DL and Duchesne, S, (eds.)
Medical Image Computing and Computer-Assisted Intervention − MICCAI 2017: 20th International Conference, Quebec City, QC, Canada, September 11-13, 2017, Proceedings, Part II.
(pp. pp. 368-376).
Springer International Publishing: Cham, Switzerland.
|
|
|
Hu, Y;
Modat, M;
Gibson, E;
Ghavami, N;
Bonmati, E;
Moore, CM;
Emberton, M;
... Vercauteren, T; + view all
(2018)
Label-driven weakly-supervised learning for multimodal deformable image registration.
In:
2018 IEEE 15th International Symposium on Biomedical Imaging.
(pp. pp. 1070-1074).
IEEE
|
|
|
Mehta, P;
Antonelli, M;
Ahmed, H;
Emberton, M;
Punwani, S;
Ourselin, S;
(2020)
Decision fusion of 3D convolutional neural networks to triage patients with suspected prostate cancer using volumetric biparametric MRI.
In:
Proceedings of SPIE. Medical Imaging 2020: Computer-Aided Diagnosis.
(pp. pp. 1-11).
Society of Photo-Optical Instrumentation Engineers (SPIE)
|
|
|
Min, Zhe;
Baum, Zachary MC;
Saeed, Shaheer U;
Emberton, Mark;
Barratt, Dean C;
Taylor, Zeike A;
Hu, Yipeng;
(2023)
Non-rigid Medical Image Registration using Physics-informed Neural Networks.
In: Frangi, Alejandro and De Bruijne, Marleen and Wassermann, Demian and Navab, Nassir, (eds.)
Information Processing in Medical Imaging: IPMI 2023.
(pp. pp. 601-613).
Springer: Cham, Switzerland.
|
|
Pocius, M;
Yan, W;
Barratt, DC;
Emberton, M;
Clarkson, MJ;
Hu, Y;
Saeed, SU;
(2024)
Weakly Supervised Localisation of Prostate Cancer Using Reinforcement Learning for Bi-Parametric MR Images.
In:
2024 IEEE International Symposium on Biomedical Imaging (ISBI).
IEEE: Athens, Greece.
|
|
Saeed, SU;
Taylor, ZA;
Pinnock, MA;
Emberton, M;
Barratt, DC;
Hu, Y;
(2020)
Prostate Motion Modelling Using Biomechanically-Trained Deep Neural Networks on Unstructured Nodes.
In: Martel, AL and Abolmaesumi, P and Stoyanov, D and Mateus, D and Zuluaga, MA and Zhou, SK and Racoceanu, D and Joskowicz, L, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2020: 23rd International Conference, Lima, Peru, October 4–8, 2020, Proceedings, Part IV.
(pp. pp. 650-659).
Springer: Cham, Switzerland.
|
|
|
Yan, W;
Yang, Q;
Huang, S;
Wang, Y;
Punwani, S;
Emberton, M;
Stavrinides, V;
... Barratt, D; + view all
(2025)
Tell2Reg: Establishing Spatial Correspondence between Images by the Same Language Prompts.
In:
Proceedings - International Symposium on Biomedical Imaging.
(pp. pp. 1-5).
IEEE
(In press).
|
|
|
Yan, Wen;
Yang, Qianye;
Syer, Tom;
Min, Zhe;
Punwani, Shonit;
Emberton, Mark;
Barratt, Dean;
... Hu, Yipeng; + view all
(2022)
The Impact of Using Voxel-Level Segmentation Metrics on Evaluating Multifocal Prostate Cancer Localisation.
In: Wu, S and Shabestari, B and Xing, L, (eds.)
Applications of Medical Artificial Intelligence, AMAI 2022.
(pp. pp. 128-138).
Springer Nature Switzerland: Cham, Switzerland.
|
Conference item
|
Brizmohun, M;
Johnston, E;
Latifoltojar, A;
O'Callaghan, J;
Bonet-Carne, E;
Ferizi, U;
Yvernault, B;
... Punwani, S; + view all
(2018)
The intracellular component of VERDICT (Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumors) MRI distinguishes Gleason 4 pattern better than Apparent Diffusion Coefficient.
Presented at: Joint Annual Meeting ISMRM-ESMRMB 2018, Paris Expo Porte de Versailles, Paris, France.
|
|
Giganti, F;
Gambarota, G;
Moore, CM;
McCartan, N;
Emberton, M;
Allen, C;
KIRKHAM, A;
(2018)
The effects of dutasteride on quantitative T2 and T2-weighted imaging in men on active surveillance for prostate cancer: results from a placebo-controlled, randomized clinical trial.
Presented at: Joint Annual Meeting ISMRM-ESMRMB 2018, Paris, France.
|
|
Marconi, L;
Stonier, T;
Tourinho-Barbosa, R;
Moore, C;
Ahmed, HU;
Cathelineau, X;
Emberton, M;
... Cathcart, P; + view all
(2019)
Site of disease recurrence following prostate focal therapy predicts oncological outcome after salvage robotic assisted radical prostatectomy.
Presented at: 114th Annual Meeting of the American Urological Association (AUA), Chicago, IL, USA.
|
|
Orczyk, C;
Hu, YP;
Gibson, E;
El-Shater Bosaily, A;
Kirkham, A;
Punwani, S;
Brown, L;
... Ahmed, HU; + view all
(2017)
Should We Aim for the Centre of an MRI Prostate Lesion? Correlation Between mpMRI and 3-dimensional 5mm Transperineal Prostate Mapping Biopsies From the PROMIS Trial.
Presented at: AUA Annual Meeting, Boston, USA.
|
|
|
Reddy, Deepika;
Peters, Max;
Shah, Taimur;
van Son, Marieke;
Bertoncelli, Mariana Tanaka;
Huber, Philipp;
Lomas, Derek;
... Ahmed, Hashim; + view all
(2022)
Focal Ablative Salvage Therapy for Radio-Recurrent Prostate Cancer: 6 Year Oncological and Safety Outcomes.
Presented at: AUA Annual Meeting 2022, 13 - 16 May 2022.
|
|
Stavrinides, V;
Giganti, F;
Stabile, A;
Allen, C;
Punwani, S;
Whitaker, HC;
Emberton, M;
(2018)
Baseline characteristics in an MRI-based active surveillance cohort: Association with clinical and histological outcomes.
Presented at: EAU 18: 33rd Annual European Association of Urology Congress, Copenhagen.
|
Poster
|
Neves, JB;
Flight, J;
Cullen, D;
Grant, L;
Walkden, M;
Bandula, S;
Patki, P;
... Tran, MGB; + view all
(2019)
Protocol for a Feasibility Study of a Cohort Embedded Randomised Controlled Trial comparing NEphron Sparing Treatment (NEST) for Small Renal Masses.
Presented at: 18th International Kidney Cancer Symposium, Miami, FL, USA.
|
|
Thesis
|
Carmona Echeverria, Lina;
(2020)
Improving The Diagnosis And Risk Stratification Of Prostate Cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Kasivisvanathan, Veerappan;
(2019)
The role of MRI-targeted biopsy in the diagnosis of prostate cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Simmons, LAM;
(2016)
Prostate cancer detection and characterisation using innovative medical imaging.
Doctoral thesis , UCL (University College London).
|
